scholarly article | Q13442814 |
P50 | author | Nathanael Gray | Q28112823 |
Elisabetta Rovida | Q55834826 | ||
Azucena Esparís-Ogando | Q57987677 | ||
Ignazia Tusa | Q63888737 | ||
Atanasio Pandiella | Q83446572 | ||
Maurizio Parola | Q37841527 | ||
Fabio Marra | Q37841541 | ||
Giovanni Di Maira | Q39637977 | ||
P2093 | author name string | Persio Dello Sbarba | |
Xianming Deng | |||
Elisa Vivoli | |||
Ezio David | |||
Nadia Navari | |||
Stefania Cannito | |||
Claudia Paternostro | |||
P2860 | cites work | Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein | Q24299360 |
Components of a new human protein kinase signal transduction pathway | Q24319086 | ||
Primary Structure of BMK1: A New Mammalian MAP Kinase | Q24324142 | ||
BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C | Q24532869 | ||
CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 | ||
Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
Big mitogen-activated kinase regulates multiple members of the MEF2 protein family | Q28137985 | ||
ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation | Q28140491 | ||
Aberrant rel/nfkb genes and activity in human cancer | Q28140722 | ||
ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression | Q28591302 | ||
Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex | Q28854310 | ||
Focal adhesion kinase: in command and control of cell motility | Q29615192 | ||
Hepatocellular carcinoma | Q29615765 | ||
Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen | Q29617963 | ||
FOXO transcription factors at the interface between longevity and tumor suppression | Q29620472 | ||
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells | Q34077207 | ||
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver | Q34078580 | ||
Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 | ||
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. | Q35202899 | ||
Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway | Q36118148 | ||
Gene expression profiles of hepatoma cell line HLE. | Q36178624 | ||
Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma | Q36625697 | ||
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions | Q37717830 | ||
Hypoxia and hypoxia inducible factors: diverse roles in liver diseases | Q37961603 | ||
ERK5 and its role in tumour development | Q37977186 | ||
ERK5: structure, regulation and function. | Q38026656 | ||
Targeting of FAK Ser910 by ERK5 and PP1delta in non-stimulated and phorbol ester-stimulated cells | Q39254626 | ||
The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs). | Q39292142 | ||
Multisite phosphorylation of Erk5 in mitosis | Q39663758 | ||
A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling | Q39904208 | ||
ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry | Q39923417 | ||
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells | Q39939949 | ||
ERK5/MAPK is activated by TGFbeta in hepatocytes and required for the GSK-3beta-mediated Snail protein stabilization. | Q39945102 | ||
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. | Q40005436 | ||
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level. | Q40135888 | ||
Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes | Q40250149 | ||
D-type cyclins | Q40443885 | ||
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells | Q41386062 | ||
The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation | Q42465515 | ||
Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress | Q42495605 | ||
Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion | Q42915741 | ||
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells | Q43495714 | ||
Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes | Q43514940 | ||
Activation of cyclin D1 expression by the ERK5 cascade | Q47670094 | ||
Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK. | Q54021741 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1454-1465 | |
P577 | publication date | 2014-09-02 | |
P1433 | published in | Gut | Q5621669 |
P1476 | title | The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma | |
P478 | volume | 64 |
Q49798105 | Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway |
Q89550782 | Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy |
Q28078572 | ERK5 and Cell Proliferation: Nuclear Localization Is What Matters |
Q52684307 | ERK5 is activated by oncogenic BRAF and promotes melanoma growth. |
Q37369392 | ERK5 kinase activity is dispensable for cellular immune response and proliferation |
Q90122397 | Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner |
Q36244298 | Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma |
Q47136711 | Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling. |
Q64065870 | Impact of ERK5 on the Hallmarks of Cancer |
Q47265464 | JNK, p38, ERK, and SGK1 Inhibitors in Cancer. |
Q39116456 | Oncogenic signaling of MEK5-ERK5. |
Q90316389 | Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors |
Q37580201 | Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. |
Q90631397 | SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation |
Q57292631 | Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells |
Q90883692 | The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells |
Q91967312 | The role of long noncoding RNAs in hepatocellular carcinoma |
Search more.